This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
C Bockting , P Spinhoven , M Koeter , L Wouters , A Schene ; Depression Evaluation Longitudinal Therapy Assessment (DELTA) Study Group (2006). Prediction of recurrence in recurrent depression and the influence of consecutive episodes on vulnerability for depression: a 2-year prospective study. Journal of Clinical Psychiatry 67, 747–755.
CE Carney , ZV Segal , JD Edinger , AD Krystal (2007). A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder. Journal of Clinical Psychiatry 68, 254–260.
C DeBattista , K Doghramji , M Menza , M Rosenthal , R Fieve (2003). Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study. Journal of Clinical Psychiatry 64, 1057–1064.
GA Fava , S Fabbri , N Sonino (2002). Residual symptoms in depression: an emerging therapeutic target. Progress in Neuro-Psychopharmacology and Biological Psychiatry 26, 1019–1027.
M Fava , AJ Rush , MH Trivedi , AA Nierenberg , ME Thase , HA Sackeim , FM Quitkin , S Wisniewski , PW Lavori , JF Rosenbaum , DJ Kupfer (2003). Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. Psychiatric Clinics of North America 26, 457–494.
M Fava , ME Thase , C DeBattista (2005). A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. Journal of Clinical Psychiatry 66, 85–93.
M Hamilton (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23, 56–61.
M Hamilton (1967). Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology 6, 278–296.
LL Judd , HS Akiskal , JD Maser , PJ Zeller , J Endicott , W Coryell , MP Paulus , JL Kunovac , AC Leon , TI Mueller , JA Rice , MB Keller (1998 a). Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. Journal of Affective Disorders 50, 97–108.
LL Judd , HS Akiskal , JD Maser , PJ Zeller , J Endicott , W Coryell , MP Paulus , JL Kunovac , AC Leon , TI Mueller , JA Rice , MB Keller (1998 b). A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Archives of General Psychiatry 55, 694–700.
N Kennedy , E Paykel (2004). Residual symptoms at remission from depression: impact on long-term outcome. Journal of Affective Disorders 80, 135–144.
AC Leon (2007). The revised warning for antidepressants and suicidality: unveiling the black box of statistical analyses. American Journal of Psychiatry 164, 1786–1789.
AC Leon , PM Marzuk , K Tardiff , A Bucciarelli , M Stajic , TM Piper , S Galea (2007). Antidepressants in adult suicides in New York City: 2001–2004. Journal of Clinical Psychiatry 68, 1399–1403.
J Mintz , LI Mintz , MJ Arruda , SS Hwang (1992). Treatments of depression and the functional capacity to work. Archives of General Psychiatry 49, 761–768.
R Mojtabai (2001). Residual symptoms and impairment in major depression in the community. American Journal of Psychiatry 158, 1645–1651.
AA Nierenberg , BR Keefe , VC Leslie , JE Alpert , JA Pava , JJ Worthington , JF Rosenbaum , M Fava (1999). Residual symptoms in depressed patients who respond acutely to fluoxetine. Journal of Clinical Psychiatry 60, 221–225.
AJ Rush , IH Bernstein , MH Trivedi , TJ Carmody , S Wisniewski , JC Mundt , K Shores-Wilson , MM Biggs , A Woo , AA Nierenberg , M Fava (2006 a). An evaluation of the Quick Inventory of Depressive Symptomatology and the Hamilton Rating Scale for Depression: a Sequenced Treatment Alternatives to Relieve Depression trial report. Biological Psychiatry 59, 493–501.
AJ Rush , M Fava , SR Wisniewski , PW Lavori , MH Trivedi , HA Sackeim , ME Thase , AA Nierenberg , FM Quitkin , TM Kashner , DJ Kupfer , JF Rosenbaum , J Alpert , JW Stewart , PJ McGrath , MM Biggs , K Shores-Wilson , BD Lebowitz , L Ritz , G Niederehe (2004). Sequenced Treatment Alternatives to Relieve Depression (STAR*D): rationale and design. Controlled Clinical Trials 25, 119–142.
AJ Rush , HC Kraemer , HA Sackeim , M Fava , MH Trivedi , E Frank , PT Ninan , ME Thase , AJ Gelenberg , DJ Kupfer , DA Regier , JF Rosenbaum , O Ray , AF Schatzberg (2006 b). Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder. Neuropsychopharmacology 31, 1841–1853.
AJ Rush , MH Trivedi , HM Ibrahim , TJ Carmody , B Arnow , DN Klein , JC Markowitz , PT Ninan , S Kornstein , R Manber , ME Thase , JH Kocsis , MB Keller (2003). The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biological Psychiatry 54, 573–583.
GE Simon (2006). How can we know whether antidepressants increase suicide risk? American Journal of Psychiatry 163, 1861–1863.
MH Trivedi , AJ Rush , HM Ibrahim , TJ Carmody , MM Biggs , T Suppes , ML Crismon , K Shores-Wilson , MG Toprac , EB Dennehy , B Witte , TM Kashner (2004). The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychological Medicine 34, 73–82.
MH Trivedi , AJ Rush , SR Wisniewski , AA Nierenberg , D Warden , L Ritz , G Norquist , RH Howland , B Lebowitz , PJ McGrath , K Shores-Wilson , MM Biggs , GK Balasubramani , M Fava (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. American Journal of Psychiatry 163, 28–40.
SR Wisniewski , AJ Rush , GK Balasubramani , MH Trivedi , AA Nierenberg , for the STAR*D Investigators (2006). Self-rated global measure of the frequency, intensity, and burden of side effects. Journal of Psychiatric Practice 12, 71–79.
M Zimmerman , MA Posternak , I Chelminski (2007). Heterogeneity among depressed outpatients considered to be in remission. Comprehensive Psychiatry 48, 113–117.